Drug-Loaded Oral Thin Films Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type (Antiulcer, Antiasthamatics, Antitussives, Antihistamines, Expectorants, NSAID'S, Others); Distribution Channel (Hospital pharmacy, Retail pharmacy, E-commerce)

Report Code: TIPRE00013501 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

United States Food and Drug Administration (USFDA) defined the fast dissolving oral thin films as "a thin, flexible, non-friable polymeric film strip containing one or more dispersed/dissolved active pharmaceutical ingredients, which is intended to be placed on the tongue for rapid in vitro disintegration or dissolution in the saliva prior to swallowing for delivery into the gastrointestinal tract". Drug-loaded oral thin films offer accurate dosing in a safe and fast environment. Drug-loaded oral thin films have an effective format that is suitable and manageable, without the need of other supporting product.

MARKET DYNAMICS

The drug-loaded oral thin films market is driving due to the technological advancement in drug discovery and development processes, less bio-availability of solid drugs. However, the expensive packaging cost in developing drug-loaded oral thin films is also effecting the production and adoption of such product which may hinder the market.

MARKET SCOPE

The "Drug-Loaded Oral Thin Films Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of drug-loaded oral thin films market with detailed market segmentation by drug type and distribution channel. The drug-loaded oral thin films market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in drug-loaded oral thin films market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The drug-loaded oral thin films market is segmented on the basis of drug type and distribution channel. On the basis of drug type, the market is categorized as antiulcer, antiasthamatics, antitussives, antihistamines, expectorants, NSAID'S and others. On the basis of distribution channel, the market is categorized hospital pharmacy, retail pharmacy and E-commerce.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the drug-loaded oral thin films market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The drug-loaded oral thin films market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting drug-loaded oral thin films market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the drug-loaded oral thin films market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the drug-loaded oral thin films market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from drug-loaded oral thin films market are anticipated to have lucrative growth opportunities in the future with the rising demand for drug-loaded oral thin films in the global market. Below mentioned is the list of few companies engaged in the drug-loaded oral thin films market.

The report also includes the profiles of key players in drug-loaded oral thin films market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  tesa Labtec GmbH
  •  BioAlliance Pharma
  •  MonoSol Rx
  •  Hughes Medical Corp.
  •  Paladin Labs
  •  ZIM Laboratories Limited
  •  Indivior plc
  •  Aquestive Therapeutics, Inc.
  •  Sumitomo Dainippon Pharma Co., Ltd.
  •  IntelGenx Corp.
  •  Pfizer, Inc.
  •  Novartis AG
  •  Allergan plc
  •  NAL Pharma

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug-Loaded Oral Thin Films Market - By Drug Type
1.3.2 Drug-Loaded Oral Thin Films Market - By Distribution Channel
1.3.3 Drug-Loaded Oral Thin Films Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG-LOADED ORAL THIN FILMS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG-LOADED ORAL THIN FILMS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DRUG-LOADED ORAL THIN FILMS MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG-LOADED ORAL THIN FILMS - GLOBAL MARKET OVERVIEW
6.2. DRUG-LOADED ORAL THIN FILMS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG-LOADED ORAL THIN FILMS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTIULCER
7.3.1. Overview
7.3.2. Antiulcer Market Forecast and Analysis
7.4. ANTIASTHAMATICS
7.4.1. Overview
7.4.2. Antiasthamatics Market Forecast and Analysis
7.5. ANTITUSSIVES
7.5.1. Overview
7.5.2. Antitussives Market Forecast and Analysis
7.6. ANTIHISTAMINES
7.6.1. Overview
7.6.2. Antihistamines Market Forecast and Analysis
7.7. EXPECTORANTS
7.7.1. Overview
7.7.2. Expectorants Market Forecast and Analysis
7.8. NSAID'S
7.8.1. Overview
7.8.2. NSAID'S Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. DRUG-LOADED ORAL THIN FILMS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACY
8.3.1. Overview
8.3.2. Hospital pharmacy Market Forecast and Analysis
8.4. RETAIL PHARMACY
8.4.1. Overview
8.4.2. Retail pharmacy Market Forecast and Analysis
8.5. E-COMMERCE
8.5.1. Overview
8.5.2. E-commerce Market Forecast and Analysis
9. DRUG-LOADED ORAL THIN FILMS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Drug-Loaded Oral Thin Films Market Overview
9.1.2 North America Drug-Loaded Oral Thin Films Market Forecasts and Analysis
9.1.3 North America Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Drug Type
9.1.4 North America Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Countries
9.1.5.1 United States Drug-Loaded Oral Thin Films Market
9.1.5.1.1 United States Drug-Loaded Oral Thin Films Market by Drug Type
9.1.5.1.2 United States Drug-Loaded Oral Thin Films Market by Distribution Channel
9.1.5.2 Canada Drug-Loaded Oral Thin Films Market
9.1.5.2.1 Canada Drug-Loaded Oral Thin Films Market by Drug Type
9.1.5.2.2 Canada Drug-Loaded Oral Thin Films Market by Distribution Channel
9.1.5.3 Mexico Drug-Loaded Oral Thin Films Market
9.1.5.3.1 Mexico Drug-Loaded Oral Thin Films Market by Drug Type
9.1.5.3.2 Mexico Drug-Loaded Oral Thin Films Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Drug-Loaded Oral Thin Films Market Overview
9.2.2 Europe Drug-Loaded Oral Thin Films Market Forecasts and Analysis
9.2.3 Europe Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Drug-Loaded Oral Thin Films Market
9.2.5.1.1 Germany Drug-Loaded Oral Thin Films Market by Drug Type
9.2.5.1.2 Germany Drug-Loaded Oral Thin Films Market by Distribution Channel
9.2.5.2 France Drug-Loaded Oral Thin Films Market
9.2.5.2.1 France Drug-Loaded Oral Thin Films Market by Drug Type
9.2.5.2.2 France Drug-Loaded Oral Thin Films Market by Distribution Channel
9.2.5.3 Italy Drug-Loaded Oral Thin Films Market
9.2.5.3.1 Italy Drug-Loaded Oral Thin Films Market by Drug Type
9.2.5.3.2 Italy Drug-Loaded Oral Thin Films Market by Distribution Channel
9.2.5.4 Spain Drug-Loaded Oral Thin Films Market
9.2.5.4.1 Spain Drug-Loaded Oral Thin Films Market by Drug Type
9.2.5.4.2 Spain Drug-Loaded Oral Thin Films Market by Distribution Channel
9.2.5.5 United Kingdom Drug-Loaded Oral Thin Films Market
9.2.5.5.1 United Kingdom Drug-Loaded Oral Thin Films Market by Drug Type
9.2.5.5.2 United Kingdom Drug-Loaded Oral Thin Films Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Drug-Loaded Oral Thin Films Market Overview
9.3.2 Asia-Pacific Drug-Loaded Oral Thin Films Market Forecasts and Analysis
9.3.3 Asia-Pacific Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Drug-Loaded Oral Thin Films Market
9.3.5.1.1 Australia Drug-Loaded Oral Thin Films Market by Drug Type
9.3.5.1.2 Australia Drug-Loaded Oral Thin Films Market by Distribution Channel
9.3.5.2 China Drug-Loaded Oral Thin Films Market
9.3.5.2.1 China Drug-Loaded Oral Thin Films Market by Drug Type
9.3.5.2.2 China Drug-Loaded Oral Thin Films Market by Distribution Channel
9.3.5.3 India Drug-Loaded Oral Thin Films Market
9.3.5.3.1 India Drug-Loaded Oral Thin Films Market by Drug Type
9.3.5.3.2 India Drug-Loaded Oral Thin Films Market by Distribution Channel
9.3.5.4 Japan Drug-Loaded Oral Thin Films Market
9.3.5.4.1 Japan Drug-Loaded Oral Thin Films Market by Drug Type
9.3.5.4.2 Japan Drug-Loaded Oral Thin Films Market by Distribution Channel
9.3.5.5 South Korea Drug-Loaded Oral Thin Films Market
9.3.5.5.1 South Korea Drug-Loaded Oral Thin Films Market by Drug Type
9.3.5.5.2 South Korea Drug-Loaded Oral Thin Films Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Drug-Loaded Oral Thin Films Market Overview
9.4.2 Middle East and Africa Drug-Loaded Oral Thin Films Market Forecasts and Analysis
9.4.3 Middle East and Africa Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Drug-Loaded Oral Thin Films Market
9.4.5.1.1 South Africa Drug-Loaded Oral Thin Films Market by Drug Type
9.4.5.1.2 South Africa Drug-Loaded Oral Thin Films Market by Distribution Channel
9.4.5.2 Saudi Arabia Drug-Loaded Oral Thin Films Market
9.4.5.2.1 Saudi Arabia Drug-Loaded Oral Thin Films Market by Drug Type
9.4.5.2.2 Saudi Arabia Drug-Loaded Oral Thin Films Market by Distribution Channel
9.4.5.3 U.A.E Drug-Loaded Oral Thin Films Market
9.4.5.3.1 U.A.E Drug-Loaded Oral Thin Films Market by Drug Type
9.4.5.3.2 U.A.E Drug-Loaded Oral Thin Films Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Drug-Loaded Oral Thin Films Market Overview
9.5.2 South and Central America Drug-Loaded Oral Thin Films Market Forecasts and Analysis
9.5.3 South and Central America Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Drug-Loaded Oral Thin Films Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Drug-Loaded Oral Thin Films Market
9.5.5.1.1 Brazil Drug-Loaded Oral Thin Films Market by Drug Type
9.5.5.1.2 Brazil Drug-Loaded Oral Thin Films Market by Distribution Channel
9.5.5.2 Argentina Drug-Loaded Oral Thin Films Market
9.5.5.2.1 Argentina Drug-Loaded Oral Thin Films Market by Drug Type
9.5.5.2.2 Argentina Drug-Loaded Oral Thin Films Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DRUG-LOADED ORAL THIN FILMS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DRUG-LOADED ORAL THIN FILMS MARKET, KEY COMPANY PROFILES
12.1. TESA LABTEC GMBH
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BIOALLIANCE PHARMA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MONOSOL RX
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. HUGHES MEDICAL CORP.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. PALADIN LABS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ZIM LABORATORIES LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INDIVIOR PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AQUESTIVE THERAPEUTICS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SUMITOMO DAINIPPON PHARMA CO., LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INTELGENX CORP.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. PFIZER, INC.
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
12.12. NOVARTIS AG
12.12.1. Key Facts
12.12.2. Business Description
12.12.3. Products and Services
12.12.4. Financial Overview
12.12.5. SWOT Analysis
12.12.6. Key Developments
12.13. ALLERGAN PLC
12.13.1. Key Facts
12.13.2. Business Description
12.13.3. Products and Services
12.13.4. Financial Overview
12.13.5. SWOT Analysis
12.13.6. Key Developments
12.14. NAL PHARMA
12.14.1. Key Facts
12.14.2. Business Description
12.14.3. Products and Services
12.14.4. Financial Overview
12.14.5. SWOT Analysis
12.14.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. tesa Labtec GmbH
2. BioAlliance Pharma
3. MonoSol Rx
4. Hughes Medical Corp.
5. Paladin Labs
6. ZIM Laboratories Limited
7. Indivior plc
8. Aquestive Therapeutics, Inc.
9. Sumitomo Dainippon Pharma Co., Ltd.
10. IntelGenx Corp.
11. Pfizer, Inc.
12. Novartis AG
13. Allergan plc
14. NAL Pharma

TIPRE00013501
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking